| Uremic Solutes Database |
| Solute Details for Phenylacetic acid |
| Switch to solute: |
|
|
| Base data |
| Name |
Phenylacetic acid |
| Molecular weight |
136 |
| Group |
other |
| Class |
Protein-bound [4] |
| Added |
01.08.2012 |
| Reference |
Pubmed: 22626821 |
| Submitted by |
Duranton |
| Reviewed by |
Abou Deif |
|
| Normal concentrations (CN) |
|
|
| Uremic concentrations (CU) |
| Date | Mean (+/-SD) (low Range - high Range) | n | Reference | Submitted by | Reviewed by | Notes | | 07.04.2004 | 474.64 (+/-44.88) mg/L | 41 | Increased plasma phenylacetic acid in... | Abou Deif | Argiles | [2] | | Grand mean | 474.64 (+/-44.88) mg/L | 41 | | | | ANOVA | | | | | Dispersion | |
|
|
| Relative increase (CU/CN) |
339.03 times higher than the average normal concentration. |
|
| Pathological associations |
| Date | Category | Reference | Comment | | 07.04.2004 | Cardiovascular | Increased plasma phenylacetic acid in... | Accumulation of phenylacetic acid in patients with end-stage renal failure [...] may contribute to increased atherosclerosis and cardiovascular morbidity. | | 10.04.2009 | Immunologic | The uraemic toxin phenylacetic acid i... | iNOS inhibition by PAA might affect immunoregulatory processes and could play a role in aggravation of immunodeficiency of patients with end-stage renal disease. |
|
|
| Notes |
| 2 | Units reported as mol/l transformed to g/l as C(g/l) = [C(mol/l) * molecular weight] | | 4 | This protein-bound solute has a molecular weight conforming to middle molecules. | | 10 | Only maximum range available, or detection limit used as maximum range. | | 16 | Excluded from analysis of variance for missing arithmetic mean, standard deviation or sample count. |
|
|
|
|